DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1NanoAlvand
03 2Ever Pharma
04 1medac
05 2Advanz Pharma
06 1Baxter Healthcare Corporation
07 2Bayer AG
08 1Chia Tai Tianqing Pharmaceutical Group
09 1DR REDDY'S LABORATORIES LTD
10 7Eisai
11 5Eisai Inc
12 1Eisai Pharmaceuticals Africa (Pty) Ltd
13 1GLAND PHARMA LIMITED
14 1GSK
15 1Glenmark Pharmaceuticals
16 1JIANGXI KVVIT PHARM
17 1Long Grove Pharmaceuticals
18 1Natco Pharma (Canada) Inc
19 3STADA Arzneimittel
20 1Sandoz B2B
21 1Viatris
22 1Xiling Lab
23 1Yes Pharmaceutical Development Services Gmbh
24 2Zentiva
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 1INJ
03 20Injectable Solution
04 1Injection
05 1Injection fluid, resolution
06 3SOLUTION
07 9SOLUTION;INTRAVENOUS
08 1Solution for Injection
09 4Blank
01 1Allowed
02 10Approved
03 8Authorized
04 1Cancelled
05 1Lead Market Dossiers- Filed
06 1Originator
07 3Prescription
08 9RX
09 7Blank
01 8ERIBULIN MESYLATE
02 1ERIBULIN MESYLATE INJECTION
03 2Eribulin Advanz Pharma
04 2Eribulin Baxter
05 1Eribulin Ever Pharma
06 1Eribulin Glenmark
07 1Eribulin Medac
08 2Eribulin Stada
09 1Eribulin Stada Arzneimittel Ag
10 1Eribulin Zentiva
11 1Eribulina Ever Pharma
12 1Eribulina Glenmark
13 1Eribulina Viatris
14 1Eribulina Zentiva
15 2HALAVEN
16 1Halave
17 10Halaven
18 1Mevlyq
19 1NAT-ERIBULIN
20 1Nibulin®
21 1Blank
01 4Australia
02 3Canada
03 1India
04 1Iran
05 1Italy
06 1Norway
07 1South Africa
08 9Spain
09 10Sweden
10 1Switzerland
11 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 217473
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Nibulin®
Dosage Form : Solution for Injection
Dosage Strength : 1MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 07/06/2024
Application Number : 20221221000240
Regulatory Info : Approved
Registration Country : Sweden
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Medac
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000183
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Eribulina Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44MG
Packaging :
Approval Date : 2024-09-30
Application Number : 89838
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Advanz Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 06/09/2023
Application Number : 20220812000027
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-10-01
Application Number : 217250
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Baxter
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 27/06/2024
Application Number : 20230427000060
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-03-04
Application Number : 218743
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : HALAVEN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2010-11-15
Application Number : 201532
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Halaven
Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Halaven
Dosage Form : Injection fluid, resolution
Dosage Strength : 0.44 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-04-05
Application Number : 218047
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Glenmark
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000152
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-07-18
Application Number : 214850
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-06-09
Application Number : 214310
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Stada
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 23/10/2023
Application Number : 20220801000069
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-08-05
Application Number : 218142
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-06-28
Application Number : 218281
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
